Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
46.58
-2.00 (-4.12%)
At close: Aug 29, 2025, 4:00 PM
46.95
+0.37 (0.79%)
After-hours: Aug 29, 2025, 7:07 PM EDT
Avidity Biosciences Market Cap
Avidity Biosciences has a market cap or net worth of $5.99 billion as of August 29, 2025. Its market cap has increased by 27.37% in one year.
Market Cap
5.99B
Enterprise Value
4.81B
1-Year Change
27.37%
Ranking
Category
Stock Price
$46.58
Market Cap Chart
Since June 12, 2020, Avidity Biosciences's market cap has increased from $1.01B to $5.99B, an increase of 494.81%. That is a compound annual growth rate of 40.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 5.99B | 72.72% |
| Dec 31, 2024 | 3.47B | 417.36% |
| Dec 29, 2023 | 670.62M | -54.52% |
| Dec 30, 2022 | 1.47B | 32.27% |
| Dec 31, 2021 | 1.11B | 16.40% |
| Dec 31, 2020 | 957.68M | -4.94% |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |